Business Description
Teladoc Health Inc
NAICS : 621999
SIC : 8011
ISIN : US87918A1051
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.71 | |||||
Equity-to-Asset | 0.53 | |||||
Debt-to-Equity | 0.69 | |||||
Debt-to-EBITDA | 10.32 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | -3.45 | |||||
Beneish M-Score | -3.1 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 9.4 | |||||
3-Year EPS without NRI Growth Rate | 36.2 | |||||
3-Year Book Growth Rate | -49.1 | |||||
Future 3-5Y EPS without NRI Growth Rate | -29.03 | |||||
Future 3-5Y Total Revenue Growth Rate | 3.24 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 54.66 | |||||
9-Day RSI | 45.99 | |||||
14-Day RSI | 42.57 | |||||
6-1 Month Momentum % | -19.9 | |||||
12-1 Month Momentum % | -44.53 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.54 | |||||
Quick Ratio | 3.47 | |||||
Cash Ratio | 2.67 | |||||
Days Inventory | 19.37 | |||||
Days Sales Outstanding | 29.87 | |||||
Days Payable | 16.52 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.5 | |||||
Shareholder Yield % | 0.07 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 70.8 | |||||
Operating Margin % | -8.09 | |||||
Net Margin % | -8.47 | |||||
FCF Margin % | 7.41 | |||||
ROE % | -9.57 | |||||
ROA % | -5.08 | |||||
ROIC % | -6.57 | |||||
ROC (Joel Greenblatt) % | -283.46 | |||||
ROCE % | -5 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Price-to-Owner-Earnings | 37.82 | |||||
PS Ratio | 0.87 | |||||
PB Ratio | 0.98 | |||||
Price-to-Free-Cash-Flow | 11.74 | |||||
Price-to-Operating-Cash-Flow | 6.48 | |||||
EV-to-EBIT | -14.17 | |||||
EV-to-Forward-EBIT | -40.16 | |||||
EV-to-EBITDA | 18.11 | |||||
EV-to-Forward-EBITDA | 10.67 | |||||
EV-to-Revenue | 1.07 | |||||
EV-to-Forward-Revenue | 1.05 | |||||
EV-to-FCF | 14.42 | |||||
Price-to-Projected-FCF | 0.92 | |||||
Earnings Yield (Greenblatt) % | -7.06 | |||||
FCF Yield % | 8.33 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Teladoc Health Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 2,414.231 | ||
EPS (TTM) (€) | -1.245 | ||
Beta | 2.01 | ||
Volatility % | 50.2 | ||
14-Day RSI | 42.57 | ||
14-Day ATR (€) | 0.348268 | ||
20-Day SMA (€) | 13.19825 | ||
12-1 Month Momentum % | -44.53 | ||
52-Week Range (€) | 12.182 - 27.42 | ||
Shares Outstanding (Mil) | 169.31 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Teladoc Health Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Teladoc Health Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Teladoc Health Inc Frequently Asked Questions
What is Teladoc Health Inc(FRA:4LL)'s stock price today?
When is next earnings date of Teladoc Health Inc(FRA:4LL)?
Does Teladoc Health Inc(FRA:4LL) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |